COMMISSION STAFF WORKING DOCUMENT Accompanying the document Report from the Commission to the European Parliament and the Council Implementation of the third Programme of Community action in the field of health in 2014
Date: 2017-04-05
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: EU programme, chronic illness, cross-border cooperation, financing method, health care system, implementation of the budget, joint action, programme budgeting, public contract, public health

EN 

   EN 

   EUROPEAN COMMISSION  Brussels, 5.4.2017  SWD(2017) 119 final/2   CORRIGENDUM  This document corrects SWD(2017) 119 final of 03.04.2017;  The table of contents has been updated.  COMMISSION STAFF WORKING DOCUMENT Accompanying the document Report from the Commission to the European Parliament and the Council Implementation of the third Programme of Community action in the field of health in 2014 {COM(2017) 149 final}  
 
 
Table of Contents 

Table of Contents 
Table of Contents .................................................................................................................................... 2 

Annex 1: Commission staff working paper linked to the above report .................................................. 4 

Introduction ......................................................................................................................................... 4 

Highlights of initiatives ending in the reporting year .......................................................................... 4 

Projects .................................................................................................................................................... 4 

EU-HEP-SCREEN — Screening for hepatitis В and C among migrants in the European Union ........... 4 

HProImmune — Promotion of immunisation for health professionals in Europe .............................. 5 

ACTION-FOR-HEALTH — Reducing health inequalities: preparation for action plans and structural 
funds projects ...................................................................................................................................... 5 

SALUX — A European network to follow-up the reformulation of food: Identification and exchange 
of good practices for SMEs and consumers ........................................................................................ 6 

PRO-YOUTH: Promotion of young people’s mental health through technology-enhanced 
personalisation of care ........................................................................................................................ 7 

E-IMD — European registry and network for intoxication type metabolic disease ............................ 8 

EuroHeart II — European heart health strategy ................................................................................. 9 

Joint actions ............................................................................................................................................. 9 

Joint action on health inequalities (equity action) .............................................................................. 9 

European partnership for action against cancer (EPAAC) ................................................................. 11 

European health and life expectancy information system (EHLEIS) ................................................. 11 

Calls for tenders .................................................................................................................................... 13 

Request for services to help implement Decision 1082/2013/EU — preparedness activities to 
monitor, assess and coordinate the response ................................................................................ 13 

Background information ................................................................................................................ 13 

Brief description ............................................................................................................................ 13 

Review and mapping of the continuous professional development of health workers ................... 15 

SEED — Overview of the legal framework for electronic health records in the Member States ..... 15 

2 

 
 
Eurocet128 — European coding systems for human tissue and cells............................................... 16 

MACELI — Macro cost-effectiveness corrected for lifestyle — Life-table analysis: health system 
cost-effectiveness assessment across Member States ..................................................................... 17 

Highlights of co-funded ‘cross-cutting’ and ‘other’ actions .................................................................. 18 

Communication and dissemination ............................................................................................... 18 

Evaluations .................................................................................................................................... 19 

Cross-delegations .......................................................................................................................... 20 

Other Actions Scientific Committees ................................................................................................ 22 

Grants and tenders by Third Health Programme objective .............................................................. 23 

Funding per thematic priority and financial instrument ............................................................... 39 

3 

 
 
 
 
Annex 1: Commission staff working paper linked to the above 
report 

Introduction 

This  Commission  staff  working  document  accompanies  the  report  on  the  implementation  of  the 
Third  Health  Programme  in  2014.  The  report  highlights  some  of  the  key  initiatives  co-funded  to 
further EU health policy and implement EU directives. This staff working document also showcases 
the results of measures funded under the Second Health Programme, which ended in 2014. It also 
presents  other  action  that  was  co-funded  in  2014  in  cross-cutting  areas  such  as  dissemination, 
evaluation and collaboration with other services. Lastly, it includes interesting statistics, and the full 
list  of  all  initiatives  co-funded  and  contracts  provided  from  the  Third  Health  Programme  operating 
budget in 2014. 

Highlights of initiatives ending in the reporting year 

Examples of the programme’s results 

Several  initiatives  co-funded  under  the  Second  Health  Programme  ended  in  2014  and  produced 
interesting results. Several examples of projects that had a significant outcome are described below. 
More information about these and other projects and joint actions and their results can be found in 
the  Health  Programme  database  managed  by  the  Consumers,  Health  and  Food  Executive  Agency 
(Chafea):  http://ec.europa.eu/chafea/health/index.html.  Please  note  that  this  database  covers  all 
actions  co-funded  under  the  Public  Health  Programme  as  well  as  the  2nd  and  the  3rd  Health 
Programmes  

Projects 

EU-HEP-SCREEN — Screening for hepatitis В and C among migrants in 
the European Union 

Background information 

The EU-HEP-SCREEN project ran from October 2011 to December 2014 with a maximum co-funding 
of  EUR 792 816.00.  It  involved  11  partners  in  six  EU  countries  (Germany,  Hungary,  Italy,  the 
Netherlands, Spain and the United Kingdom). 

Brief description 

The  general  objective  of  this  project  was  to  assess,  describe  and  communicate  to  public  health 
professionals the tools and conditions necessary to implement successful screening programmes for 
hepatitis В and C among migrants in the European Union, since viral hepatitis is still a major health 
concern in the EU. 

Central to the project were four pilot studies using different screening strategies: 

1)  information and outreaching, combined with testing through local general practitioners; 
2)  combined information and testing on location; 

4 

 
 
3)  opportunistic and systematic case finding in general practice; and 
4)  case finding through existing screening programmes. 

The  project  created  a  tool  kit  to  allow  public  health  professionals  to  design  effective  screening 
programmes in their country or region, specifically targeting migrants. 

Specific results 

The  project  laid  the  foundation  for  the  expansion  of  nationwide  screening  and  prevention 
programmes for hepatitis B and C among migrants in the EU. A comprehensive overview and analysis 
of knowledge on the clinical management of hepatitis B and C in migrants, an appraisal of alternative 
screening  strategies,  and  methods  for  effective  communication  to  the  target  population  were 
assessed.  The  project  also  defined  best  practices  for  screening  and  developed  a  tool  kit  —  see: 
http://hepscreen.eu/ 

HProImmune — Promotion of immunisation for health professionals in 
Europe 

Background information 

The HProImmune project ran from September 2011 to August 2014 with a maximum co-funding of 
EUR 603 900.00. It involved nine partners from seven EU countries (Cyprus, Germany, Greece, Italy, 
Lithuania, Poland and Romania). 

Brief description 

The  general  objective  of  the  project  was  to  promote  immunisations  and  increase  vaccination 
coverage  in  health  care  workers  by  developing  a  tailored  communications  tool-kit.  It  focused  on  a 
limited number of priority vaccines. It addressed the needs and perspectives of medical personnel in 
primary health care as well as hospital and public health personnel. The communications tool-kit is 
meant  to  create  awareness  and  contribute  to  the  protection  of  health  care  workers,  especially  in 
emergency responses. The kit includes recommendations, communication guidelines and fact sheets. 

Specific results 

HProImmune  reviewed,  summarised  and  widely  disseminated  existing  information  and  best 
practices. It also used qualitative and quantitative analysis to explore behaviours and barriers to the 
immunisation  of  health  care  workers.  This  evidence  was  used  to  develop  a  comprehensive 
communications  tool-kit.  This  kit  supports  public  health  authorities  and  hospital  administrators  in 
planning  and  organising  successful  immunisation  activities,  thereby  helping  to  achieve  national 
strategic  goals  for  increasing vaccination coverage,  especially in  the case  of  seasonal  influenza.  For 
more information, visit: http://www.hproimmune.eu/ 

ACTION-FOR-HEALTH — Reducing health inequalities: preparation for 
action plans and structural funds projects 

Background information 

5 

 
 
The ACTION-FOR-HEALTH project ran from August 2012 to September 2014 with a maximum co-
funding of EUR 588 862.96. It involved partners from 10 countries EU countries: Bulgaria, Croatia, 
Estonia, Hungary, Lithuania, the Netherlands, Slovakia, Slovenia, Spain and the United Kingdom. 

Brief description 

The  general  objective  of  the  project  was  to  help  improve  health  and  quality  of  life  by  increasing 
stakeholders’  capacity  to  access  structural  funds  as  a  means  of  supporting  health  promotion 
interventions. This increased capacity was not strictly targeted at the health sector, but by adopting a 
‘Health in All Policies’ approach, the project also engaged actors in different sectors such as health, 
education,  employment  and  the  environment.  The  project  contributed  to  building  capacity  to 
effectively tackle health inequalities by developing regional action plans based on situational analysis 
and needs assessments. 

Specific results 

Seven  European  regions  were  chosen  as  pilot  sites.  Action  plans  were  developed  for  each  region 
based  on  a  robust  bottom-up  approach  already  tested  and  implemented  in  Slovenia.  The 
methodology aimed to align an initiative promoting a healthy lifestyle (aimed particularly at reaching 
vulnerable groups) with one regional development strategic objective. This was followed by tailored-
made  training  activities  designed  to  build  the  capacity  of  local/regional/national  public  health 
professionals and authorities, civil society and academic institutions. 

The  main  output  of  the  project  was  a  tool-kit  for  creating  action  plans  at  regional/national  level, 
taking local capacity and skills and cultural and environmental differences into account to ensure the 
transferability  of  competencies.  The  project  developed  a  distance  learning  tool-kit  for  use  in  the 
longer term. All training material, publications and tools can be found here: http://www.action-for-
health.eu/ 

SALUX — A European network to follow-up the reformulation of food: 
Identification and exchange of good practices for SMEs and consumers 

Background information 

The  SALUX  project  ran  from  July  2011  to  July  2014  with  a  maximum  co-funding  of  EUR  834 688.  It 
involved 17 partners in 12 EU countries (Austria, Bulgaria, Finland, France, Germany, Hungary, Italy, 
Lithuania, Romania, Slovenia, Spain and the United Kingdom). 

Brief description 

The  general  objective  of  the  SALUX  project  was  to  follow-up  the  reformulation  of  manufactured 
foods  in  order  to  promote  healthier  ways  of  life  and  reduce  major  diseases.  The  partners  worked 
with small and medium enterprises (SMEs), food industry associations, consumer associations, public 
authorities  and  NGOs  from  the  participating  countries.  SALUX  addressed  the  reformulation  of 
manufactured food by exchanging good practices and thus reducing fat, saturated and trans-fats, salt 
and sugar levels. The project focused on the technical and economic aspects of the reformulations 

6 

 
 
for  SMEs.  SALUX  collected,  processed  and  analysed  comparable  data  and  information  from  each 
Member State involved. 

Specific results 

The SALUX  project  established  a  European  Infobase  on  healthy  manufactured food which  could  be 
used  by  agri-food  SMEs  and  consumers.  Another  main  achievement  was  the  exchange  of  good 
practices  on  reformulating  food,  and  on  stimulating  the  production  and  consumption  of 
reformulated food. 

The  project  also  developed  a  cost  assessment  tool  to  help  SMEs  estimate  the  potential  costs  and 
benefits of reformulating their food products. In developing this instrument, a cost analysis of major 
reformulations  was  conducted.  The  follow-up  of  the  food  reformulation  among  SMEs  in  the 
participating countries built a better understanding of the problems and barriers that SMEs face and 
their  concerns  with  regard  to  the  reduction  of  salt,  saturated  fats,  trans-fats  or  sugars  in 
manufactured food. A series of reports on food reformulation is available at the following address: 
http://www.salux-project.eu/ 

PRO-YOUTH: Promotion of young people’s mental health through 
technology-enhanced personalisation of care 

Background information 

The  PRO-YOUTH  project  ran  from  April  2011  to  March  2014  with  a  maximum  co-funding  of 
EUR 872 183.45. It involved seven partners from seven EU countries (the Czech Republic, Germany, 
Hungary, Ireland, Italy, the Netherlands and Romania). 

Brief description 

The  general  objective  of  PRO-YOUTH  was  to  promote  the  knowledge  on  mental  health  issues  in 
young  people  aged  15  to  25  through  personalised,  stepped  care  integrating  the  prevention,  early 
diagnosis,  immediate  intervention  and  appropriate  management  of  eating  disorder-related  mental 
health problems. Specifically, the project aimed to improve young people’s quality of life by reducing 
the number of individuals affected by an eating disorder and minimising the burden and duration of 
suffering for those affected. 

Moreover, PRO-YOUTH focused on reducing inequalities, reaching underserved populations and de-
stigmatising  mental  disorders  through  psycho  education  and  peer  support.  The  project  involved 
young  people  in  the  development  and  implementation  of  an  online  platform.  PRO-YOUTH 
emphasised a close collaboration with local and regional authorities and health institutions. 

Specific results 

The main result was a nine-language PRO-YOUTH online support platform. It provides young people 
with easy, low-threshold and anonymous access to quality information, psycho-education and peer 
and  professional  support  in  order  to  strengthen  their  self-management  skills.  The  platform  also 
promotes mental health, counteracts the development of eating disorders and helps young people 

7 

 
 
access  professional  care  if  they  need  it.  The  PRO-YOUTH  platform  consists  of  several  modules, 
including: 

  psycho-educational materials; 
  online screening; 
  monitoring and feedback tools; 
  moderated forums; and 
  psychologist-led online counselling. 

Several  studies  performed  as  part  of  PRO-YOUTH  indicated  that  participating  in  the  PRO-YOUTH 
online  programme  helped  reduce  psychological  distress,  improved  participants’  self-management 
skills and helped them access conventional mental health care in serious cases. 

E-IMD — European registry and network for intoxication type metabolic 
disease 

Background information 

The  E-IMD  project  ran  from  January  2011  to  January  2014  with  a  maximum  co-funding  of 
EUR 747 706.37.  It  involved  12  partners  from  10  different  countries  (Croatia,  Denmark,  France, 
Germany, Italy, the Netherlands, Poland, Portugal, Spain and the United Kingdom). 

Brief description 

The E-IMD project aimed to improve the health of people affected with rare organic acidurias (OAD) 
and urea cycle defects (UCD). It did so by 

  establishing a European patient registry; 
  providing information to both national and EU level actors; and 
  developing European evidence-based consensus care protocols for patients. 

Specific results 

The  project  produced  a  unique  web-based  password-protected  registry  for  patients  with  OAD  and 
UCD, and other rare intoxication type metabolic diseases (IMD). The registry covers 15 EU countries 
and  describes  the  diseases’  course,  epidemiology,  diagnostic  and  therapeutic  strategies.  It  also 
includes  significant  clinical  evidence  and  an  in-depth  standardised  assessment  (covering  age  at 
diagnosis,  first  symptoms,  frequency  and  duration  of  hospitalisations,  medical  and  developmental 
history, physical and neurological examination, MRI studies, neuropsychological tests, and quality of 
life assessment). 

The project also developed clinical guidelines on OAD and UCD for patients, health professionals and 
the wider public. Published in over 11 languages, these guidelines aim to: 

  help  the  general  public  and  the  target  groups  gain  a  better  understanding  of  these  rare 

diseases; 
find efficient methods of combating them (including specialised centres of care); and 
improve prevention. 

 
 

8 

 
 
 
 
Reaching beyond the project’s consortium, E-IMD mobilised more than 80 organisations (60 of them 
clinical partners) from 24 countries. It has thus established links between health care professionals, 
patient representatives, industry and government authorities within Europe, candidate countries, the 
US, Canada and Australia. 

EuroHeart II — European heart health strategy 

Background information 

The  EuroHeart II  project  ran  from  March  2011  until  February  2014  with  a  maximum  co-funding  of 
EUR 911 221.05.  EuroHeart II  was  carried  out  by  30  partner  organisations  from  17  countries 
(Belgium,  the  Czech  Republic,  Finland,  France,  Germany,  Hungary,  Iceland,  Ireland,  Italy,  the 
Netherlands, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden and the United Kingdom). 

Brief description 

The EuroHeart II project analysed cardio-vascular disease (CVD) statistics across Europe, and assessed 
optimal  approaches  to  CVD  prevention,  highlighting  how  policies  could  be  used  to  reduce  the 
prevalence  of  the  major  cardiovascular  risk  factors,  with  a  focus  on  diet/nutrition  and  physical 
activity. 

Specific results 

EuroHeart II produced two key studies: ‘European Cardiovascular Disease Statistics — 2012 edition’ 
and  ‘Trends  in  age-specific  coronary  heart  disease  mortality  in  the  European  Union  over  three 
decades: 1980-2009’. 

It also  produced  two  major  reports:  ‘Identifying the  most effective  and cost-effective  public  health 
nutrition  policy  options  for  CVD  prevention’  and  ‘Coronary  Heart  Disease  mortality  projections  to 
2020 — comparing different policy scenarios’. 

These documents inform decision-makers and help them to develop CVD prevention policies based 
on  the  most  up-to-date  statistical  and  economic  data,  analyses  and  scientific  impact  models.  They 
also  provide  evidence  for  wider  stakeholders  groups  to  assess  and  address  the  situation  in  their 
countries. 

Joint actions 

Joint action on health inequalities (equity action) 

Background information 

The joint action on health inequalities (equity action) ran from February 2011 to February 2014 with 
a  maximum  co-funding  of  EUR 1 699 999.00.  It  involved  25  partners  from  15  EU  countries  and 

9 

 
 
 
 
 
Norway  (Belgium,  the  Czech  Republic,  Finland,  France,  Germany,  Greece,  Hungary,  Ireland,  Italy, 
Latvia, the Netherlands, Poland, Spain, Sweden and the United Kingdom). 

Brief description 

Equity Action’s main objectives were to: 

  help reduce health inequalities by developing knowledge for action on health inequalities; 
 

support the engagement of Member States, regions and other stakeholders in measures to 
tackle socioeconomic and geographic health inequalities; 
share learning between Member States and other actors; and 
support  the  development  of  effective  action  to  tackle  socioeconomic  health  inequalities  at 
the European policy level. 

 
 

In this regard, Equity Action directly supported the Commission Communication ‘Solidarity in Health’1 
by: 

  developing ways to audit health inequalities; 
 

including  health  inequalities  as  one  of  the  priorities  of  the  ongoing  cooperation  on  health 
between the European regions and the Commission; 
reviewing the ways to help Member States make better use of Cohesion policy and Structural 
Funds to support activities addressing health inequalities; and 

 

  developing  ways  to  encourage  stakeholders  at  European  level  to  promote  the  uptake  and 

dissemination of good practice. 

Specific results 

Equity Action’s primary outcome was increasing the involvement of  the partners and helping them 
learn from each other how to tackle socioeconomic and area-based inequalities in health. It led to a 
greater consensus on approaches which work, and increased partners’ knowledge and awareness of 
tools and methods which promote a cross-government equity focus. 

Equity Action also helped the regions become more involved in EU-wide work, in particular through 
the Council of Regions. In this way, new stakeholders participated in a number of themes, thereby 
increasing  knowledge  of  the  potential  levers  and  drivers  of  cross-sectoral  work  to  meet  equity 
standards. 

The  joint  action  also  looked  at  the  drafting  process  of  the  2014-20  structural  funds  guidelines.  It 
aimed  to  identify  how  the  guidelines  could  be  used  more  effectively  to  address  inequalities  at 
regional level and ensure the effective use of the funds for tackling inequalities in health. For more 
information, visit: http://www.equityaction-project.eu 

1 Communication from the Commission to the European Parliament, the Council, the European Economic and 
Social Committee and the Committee of the Regions — Solidarity in health: reducing health inequalities in the 
EU {SEC(2009) 1396} {SEC(2009) 1397} /* COM/2009/0567 final; http://eur-lex.europa.eu/legal-
content/EN/TXT/HTML/?uri=CELEX:52009DC0567&from=EN. 

10 

 
 
 
 
                                                            
European partnership for action against cancer (EPAAC) 

Background information 

EPAAC was launched in 2009, after the European Commission published its Communication on Action 
Against Cancer: European Partnership.2 It ran as a joint action from April 2011 to February 2014 with 
a  maximum  co-funding  of  EUR 3 103 668.94.  It  involved  38  partners  from  12  EU  countries  and 
Norway (Belgium, Finland, France, Ireland, Italy, Malta, Poland, Portugal, the Netherlands, Slovenia, 
Spain and the United Kingdom). 

Brief description 

The  EPAAC  contributed  to  better  knowledge  of  and  information  on  the  prevention,  diagnosis  and 
control  of  cancer  as  an  ageing-related  topic.  The  project  placed  emphasis  on  promoting  a  healthy 
lifestyle,  helped  to  identify  the  causes  of  cancer  inequalities  within  the  EU  and  exchange  the  best 
practices  to  tackle  them.  EPAAC  provided  considerable  added  value  in  tackling  major  health 
challenges  more  effectively,  through  information  sharing  and  the  exchange  of  expertise  and  best 
practices. 

Specific results 

EPAAC  helped  improve  the  quality  of  cancer-related  health  care  across  the  participating  countries 
and  the  quality  of  life  for  target  audiences  and  citizens  alike.  Partners  were  supported  in  the 
development of their national cancer plans. The national cancer plans are public health programmes 
designed  to  ensure  the  coordinated  and  centrally-managed  implementation  of  evidence-based 
strategies  for  prevention,  early  detection,  diagnosis,  treatment,  rehabilitation,  palliation  and 
research for innovative solutions. 

EPAAC’s activities also played a part in developing a higher awareness of the importance of cancer 
prevention. It helped improve the early diagnosis of cancer across Member States and enhance the 
medical  knowledge  of  health  professionals  regarding  screening  and  early  diagnosis.  EPAAC  also 
improved the treatments given to patients and optimise financial resources and spending for cancer 
research. Finally, data concerning cancer are now readily available in a united EU data map. For more 
information, visit: http://www.epaac.eu/ 

European health and life expectancy information system (EHLEIS) 

Background information 

2 Communication from the Commission to the European Parliament, the Council, the European Economic and 
Social Committee and the Committee of the Regions of 24 June 2009 on Action against Cancer: European 
Partnership [COM(2009) 291 final — Not published in the Official Journal]. http://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=URISERV%3Asp0011. 

11 

 
 
 
                                                            
EHLEIS  is  a  pan-European  multi-dimensional  project  that  ran  from  2007  to  2014.  As  of  2011,  the 
project  functioned as  a  joint action  within the  framework of  the  new  Europe  2020  Strategy (2011-
2020)  and  had  a  maximum  co-funding  of  EUR 637 158.00.  It  involved  21  partners  from  10  EU 
countries (Belgium, the Czech Republic, Denmark, France, Germany, Greece, Italy, the Netherlands, 
Sweden and the United Kingdom). 

Brief description 

From  2007  onwards,  the  EHLEIS  project  began  to  systematically  monitor  health  trends  and  gaps 
among the European countries. It began to identify what brought about these trends and gaps using 
the survey instruments developed by the European Health Expectancy Monitoring Unit3 and included 
in  the  new  pan-European  survey  of  European  Statistics  on  Incomes  and  Living  Conditions4  and  the 
Survey on Health, Ageing and Retirement in Europe.5 

In the framework of the new Europe 2020 Strategy (2011-2020), the EHLEIS joint action aimed to: 

 

increase  the  utility  of  the  summary  measures  of  population  health  by  consolidating  and 
further developing the EHLEIS Information System; 

  make EHLEIS more comparable with summary measures of population health for the United 

States and Japan; and 
increase Member States’ use of EHLEIS in national policy-making. 

 

EHLEIS also contributed to the European Innovation Partnership on Active and Healthy Ageing. 

Specific results 

The  main  outcome  of  EHLEIS  was  the  creation  of  an  information  system  that  made  it  possible  to 
calculate  various  health  indicators  (prevalence,  life  expectancy  and  health  expectancy)  online.  This 
meant  that  all  healthy  life  years-related  websites  were  reorganised  under  a  new  EHLEIS  umbrella 
website. 

Annual  country  reports  on  health  expectancy  were  also  translated  into  18  national  languages, 
improved  statistical  tools  for  attribution  and  decomposition  were  created  and  tested,  technical 
reports and scientific papers on key methodological advances and substantive results on inequalities 
between  Member  States  and  potential  drivers  were  published  and  a  blueprint  for  internationally 
harmonised  summary  measures  of  public  health  was  written.  Since  2015  EHLEIS  is  part  of  the 
BRIDGEHEALTH project6. For more information, visit: http://www.eurohex.eu/ 

3 European Health Expectancy Monitoring Unit; http://www.ehemu.eu/. 

4 http://ec.europa.eu/eurostat/web/income-and-living-conditions/overview. 

5 http://www.share-project.org/. 

6 http://www.bridge-health.eu/content/bridge-health-project 

12 

 
 
 
                                                            
Calls for tenders 

Request  for  services  to  help  implement  Decision  1082/2013/EU  —  preparedness 

activities to monitor, assess and coordinate the response 

Background information 
In  its  conclusions  of  13  September  2010,7  the  Council  invited  the  Commission  to  report  on  and 
develop  a  mechanism  for  the  joint  procurement  of  vaccines  and  antiviral  medication  which  would 
allow  Member  States,  on  a  voluntary  basis,  ‘to  adopt  common  approaches  to  the  negotiation  of 
contracts with the industry, which would clearly address issues such as liability, availability and the 
price of medicinal products, as well as confidentiality’. 

The legal basis for the joint procurement of medical countermeasures has been laid down in Article 5 
of  Decision 1082/2013/EU  on  serious  cross-border  threats  to  health.8  The  Joint  Procurement 
Agreement  for  medical  countermeasures9  is  intended  to  implement  this  Article.  Currently,  the 
preparations for the joint procurement  procedure for pandemic vaccines are ongoing.  The high-level 
hearing  on  seasonal  influenza  vaccination  organised  under  this  contract  aimed  to  support  Member 
States’  efforts  to  implement  the  Council  Recommendation  on  seasonal  influenza  vaccination 
(2009/1019/EU) in order to increase seasonal influenza vaccination coverage rates. This is in line with 
the  Council  conclusions  on  vaccinations  as  an  effective  tool  in  public  health,  which  invite  the 
Commission to identify synergies between the promotion of national immunisation programmes and 
the  need  to  develop  integrative  and  coherent  approaches  for  better  preparedness  at  EU-level  on  the 
basis of Decision 1082/2013/EU. 

These  services  were  provided  under  an  existing  framework  contract  held  by  a  consortium  led  by 
Public  Health  England  (UK).  The  contract  ran  from  January  2015  to  August  2015  and  was  worth 
EUR 643 559.25. 

Brief description 

The contractor was asked to provide three different services: 

 

a  seminar  addressing  the  inter-sectoral  dimension  of  preparedness  and  response  planning  at 
Union  level,  including  identifying  critical  sectors  for  the  preparedness  and  management  of 
health crises, and developing criteria; 

Conclusions 

7 
http://ec.europa.eu/health/preparedness_response/docs/council_lessonsh1n1_en.pdf. 

3032nd 

General 

Affairs 

from 

the 

Council 

meeting, 

available 

at: 

8 Article 5(1) of Decision 1082/2013/EU provides that: ‘The institutions of the Union and any Member States which so desire 
may  engage  in  a  joint  procurement  procedure  (…)  with  a  view  to  the  advance  purchase  of  medical  countermeasures  for 
serious cross-border threats to health’. 

9 The Joint Procurement Agreement was signed by the Commission on 20 June 2014. In November 2015 the Agreement had 
following  webpage: 
been  signed  by 
http://ec.europa.eu/health/preparedness_response/joint_procurement/jpa_signature_en.htm . 

the  Member  States;  please  see  details  under 

the  majority  of 

the 

13 

 
 
 
                                                            
 

a  study  on  situational  analysis  and  reporting  capacities  in  the  EU  including  possible 
technological support to follow up incidents involving environmental health threats and health 
threats from other biological agents and chemical agents; and 

  preparatory  actions  (assessments)  and  organisation  of  a  workshop  on  joint  procurement  of 
medical  countermeasures,  as  well  as  a  high-level  hearing  on  the  implementation  of  the 
Council Recommendation on seasonal influenza vaccination. 

The seminar took place on 19-21 May 2015. The participants came from 19 EU Member States and 
Norway,  the  European  Centre  for  Disease  Control  and  the  World  Health  Organisation.  The 
presentations  illustrated  the  cooperation  between  different  sectors  in  several  scenarios.  Participants 
contributed with  posters describing inter-sectoral cooperation  to ensure emergency preparedness and 
appropriate  emergency  responses  in  their  own  countries.  The  workshop  concluded  with  several 
recommendations for changes. 

The study was carried out in order to ascertain the monitoring and reporting processes for biological, 
environmental and chemical health threats. A survey among EU/EEA countries and organisations led 
to 13 recommendations for future priorities and the further work to be undertaken in the area. 

The workshop and high-level hearing took place on 29-30 April 2015. More than 100 participants 
came  from  EU  Member  States,  non-EU  state  actors,  international  organisations,  pharmaceutical 
companies  and 
representative  organisations.  Bilateral  meetings  between  Member  States’ 
representatives and pharmaceutical companies were also part of the programme. 

The purpose of the workshop was to ensure that all stakeholders involved in the joint procurement of 
pandemic  vaccines  organised  under  the  Joint  Procurement  Agreement  for  medical  countermeasures 
gained  a  complete  and  transparent  understanding  of  all  aspects  that  significantly  influence  the 
procedure. The results of the workshop will be used by the Specific Procurement Procedure Steering 
Committee for pandemic vaccines in discussions on outstanding issues related to this procurement and 
to further elaborate and finalise the specifications of the call for tender for pandemic vaccines. They 
will also be used by the Member States to update their needs analysis. 

The  objective  of  the  high-level  hearing  on  seasonal  influenza  was  to  identify,  on  the  basis  of 
demonstrated  best  practices,  concrete  measures  which  can  increase  influenza  vaccination  coverage 
rates in Member States. The results of the hearing are meant to inform further Commission report on 
the  state  of  play  on  implementing  the  Council  Recommendation  on  seasonal  influenza  vaccination. 
The  findings  of  this  hearing  are  also  intended  to  inform  the  Commission’s  policy  on  vaccination, 
which  aims  to  support  Member  States  in  their  efforts  to  share  data  and  best  practices  on  national 
vaccination policies in the context of strengthened preparedness. This is in line with the objectives of 
the Council conclusions on vaccination as an effective tool in public health.10 

10 http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/145973.pdf. 

14 

 
 
 
 
 
                                                            
Review and mapping of the continuous professional development of 
health workers 

Background information 

The review and mapping were performed through a service contract awarded to an external service 
provider, following a call for tender. It took place between October 2013 and October 2014 at a cost 
of EUR 198 735.00. 

Brief description 

This study contributed actively to implementing  the action plan for the EU health workforce which 
was adopted as part of the Commission’s Communication ‘Towards a job-rich recovery’ and aims to 
boost  jobs  in  the  health  sector.  The  contractor  mapped  and  reviewed  continuous  professional 
development (CPD) and lifelong learning for doctors, nurses, dentists, midwives and pharmacists in 
the 28 Member States and in the EFTA countries. The final report describes the policy background to 
the  topic,  reviews  available  literature  and  illustrates  the  outcomes  of  a  Europe-wide  survey  and 
expert workshop. It also presents an overview of EU and European-level initiatives on CPD. 

Specific results 

The  study  identifies  policy  recommendations  to  strengthen  the  exchange  of  cooperation  and  best 
practices at European level. It also highlights the need for efforts to allow all health professionals to 
undertake  CPD  and  to  address  the  main  barriers,  namely  lack  of  time  and  resources.  The 
recommendations also call for more research into CPD and its relation to patient safety and quality of 
care. 

SEED — Overview of the legal framework for electronic health records 
in the Member States 

Background information 

The  SEED  study  was  performed  by  an  external  contractor  following  a  call  for  tender.  It  took  place 
from December 2013 to August 2014 at a cost of EUR 284 965.00. 

Brief description 

15 

 
 
 
 
 
 
 
 
The aim of the SEED study was to create an overview of the national laws on electronic health 
records in the Member States and the extent to which they ensure cross-border eHealth services in 
accordance with Article 11 and Article 14 of Directive 2011/24/EU11. 

The study’s specific goals were to identify legal barriers for the cross-border exchange of electronic 
health  data  and  to  provide  recommendations  to  the  eHealth  network  regarding  the  changes  to 
national laws and European frameworks needed to support cross-border eHealth services. 

Specific results 

The  final  report  sets  out  recommendations  for  national  and  EU-level  measures  to  improve  the 
legal  and  security  aspects.  The 
interoperability  of  electronic  health  record  systems  and 
recommendations  were  based  on  the  findings  of  a  comparative  analysis  which  included  national 
reports  on  legal  barriers  and  good  practices  identified  by  stakeholders,  and  the  conclusions  of  an 
expert group workshop. 

Eurocet128 — European coding systems for human tissue and cells 

Background information 

The  Eurocet128  service  contract  was  concluded  in  response  to  a  call  for  tender.  It  ran  from 
December 2011 to August 2014 at a cost of EUR 449 470.00. 

Article 8(1) of Directive 2004/23/EC12 stipulates that all tissues and cells procured, processed, stored 
or  distributed  in  European  Member  States  need  to  be  traced  from  the  donor  to  the  recipient  and 
vice-versa. Article 25 of the same Directive requires that Member States establish a system for the 
identification of human tissues and cells, in order to ensure traceability. This Article also requires the 
Commission,  in  cooperation  with  the  Member  States,  to  design  a  single  European  coding  system 
(Single European Code SECode) to provide information on the main characteristics and properties of 
tissues and cells. 

Brief description 

The  objective  of  the  Eurocet128  contract  was  to  create  a  web-based  single  European  coding 
application  (the  EU  coding  platform)  that  allocates  an  SECode  to  all  the  donated  material  at  the 
tissue  establishment.  This  is  aimed  at  ensuring  that  donors  are  properly  identified  and  the 
traceability  of  all  donated  material,  and  at  providing  information  on  the  main  characteristics  and 
properties of tissues and cells. 

11 Directive 2011/24/EU of the European Parliament and of the Council, of 9 March 2011, on the application of 
patients’ rights in cross-border healthcare, http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:en:PDF 

12 Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004, on setting standards 
of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution 
of human tissues and cells, http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF 

16 

 
 
                                                            
Furthermore,  this  service  contract  has  created  a  compendium  of  tissue  and  cells  establishments  in 
the EU (the EU Tissue Establishments Compendium), and a compendium of tissues and cells products 
and their respective alpha-numeric SECodes (the EU Tissue and Cell Product Compendium). 

The EU coding platform will allow free, public access to the EU Tissue Establishments Compendium 
and  the  EU  Tissue  and  Cell  Product  Compendium.  User  manuals  can  be  downloaded  from  the 
platform. The EU coding platform will be accessible via the European Commission’s website13. 

Specific results 

This service contract has delivered a new set of databases to help ensure that tissues and cells in the 
EU can be traced from donor to recipient. These databases will be used from 2016 onwards by over 
2 000 tissue establishments in the EU and by over 50 national competent authorities. For more 
information, see: 
http://ec.europa.eu/health/blood_tissues_organs/docs/tissues_single_european_code_en.pdf 

MACELI — Macro cost-effectiveness corrected for lifestyle — Life-table 
analysis: health system cost-effectiveness assessment across Member 
States 

Background information 

This service contract was concluded in response to a call for tender. The price was EUR 249 834.00. 
The contract ran from November 2013 to November 2014. 

Brief description 

The  study’s  objective  was  to  provide  a  complex  analysis  of  cost-effectiveness  in  health  systems 
across  Member  States.  This  would  allow  European  decision-makers  to  choose  the  correct  strategic 
alternatives for the future of its health care systems, particularly with regard to lifestyle-associated 
risks.  The  study  also  aimed  to  disentangle  some  of  the  complexities  inherent  to  measuring  health 
system performance at population level. It responded to the Council conclusions of 6 June 2011 on 
moving  towards  modern,  responsive  and  sustainable  health  systems,  which  invited  the  Member 
States  and  the  Commission  to  cooperate  in  measuring  and  monitoring  the  effectiveness  of  health 
investments. 

Specific results 

The study covered all EU-28 Member States, Iceland and Norway. The baseline analyses of this study 
(without  standardising  for  lifestyle)  showed  on  average  more  health  spending  was  associated  with 
better health. This causality was clearest for countries with lower levels of spending. Standardisation 
towards  a  better  lifestyle  meant  an  upward  shift  of  the  health  production  function,  but  did  not 

13 http://ec.europa.eu/health/blood_tissues_organs/tissues/single_european_code/index_en.htm 

17 

 
 
 
                                                            
significantly  alter  the  comparative  efficiency  of  countries.  The  full  report  is  available  here: 
http://ec.europa.eu/health/systems_performance_assessment/docs/2015_maceli_report_en.pdf. 

Highlights of co-funded ‘cross-cutting’ and ‘other’ actions 

Communication and dissemination 

Dissemination activities carried out in 2014 

In  2014,  the  Consumer,  Health,  Agriculture  and  Food  Executive  Agency  (Chafea)  carried  out  many 
activities in order to widely disseminate the results of initiatives co-funded under the Second Health 
Programme. The aim was to shift dissemination from the centralised level more to the Member State 
level. This is why, as a first step,  the National Focal Points had been consulted in 2013 about their 
preferences  in  terms  of  important  health  topics,  dissemination  instruments,  etc.  A  list  of  priority 
topics  and  dissemination  means  was  decided  based  on  this  consultation.  As  a  result,  three 
conferences were organised, and three thematic brochures and several info-sheets were produced. 
Chafea also used many national health conferences as a platform for dissemination. 

Conference  on  health  inequalities  and  vulnerability:  Capacity  building  and  interventions 

The  three  conferences  organised  in  collaboration  with  the  Ministry  of  Health  in  the  host  country 
were: 
1) 
among EU Member States (20-21 October, Rome, Italy); 
2) 
Belgium); 
3) 

Health  Security  Workshop:  How  to  benefit  from  EU  projects?  (13-14  November,  Brussels, 

Regional conference on rare diseases (2-3 December 2014, Prague, Czech Republic). 

All  events  were  web-streamed.  This  substantially  increased  audience  numbers,  with  200  to  300 
viewings on average per day. 

Chafea has also produced several info-sheets. These are brief documents summarising and analysing 
the  implemented  measures  and  their  outcomes,  co-funded  under  the  Second  Health  Programme 
with  special  relevance  to  the  EU  policy  in  specific  public  health  areas.  The  info-sheets  specifically 
target  health  policy  makers  at  national  level.  In  2014,  info-sheets  on  health  inequalities,  health 
security and rare diseases were produced, corresponding to the  themes of the above conferences. 
Many other info-sheets followed in 2015, all of which were translated into all EU languages. 

Three new brochures were produced in 2014: 

  Action on Health Inequalities in the EU; 
  An overview of the EU Health Programme support to tackle HIV/AIDS and co-infections; 
  Nutrition and Physical Activity Actions addressing Obesity. 

18 

 
 
 
 
 
 
info-sheets 

The 
http://ec.europa.eu/chafea/publications/publications_for_health_programme.html. 

brochures 

available 

and 

are 

on 

Chafea’s 

website: 

Lastly,  Chafea  organised  workshops  showcasing  pertinent  actions  at  national  conferences  and 
handed out print materials at the Health Programme’s info-booth. These conferences included: 

 
 

 
 
 

the 11th Nordic Public Health Conference (Trondheim, NO, August 2014); 
the 
‘Increasing  Capacities,  Achieving  Novelty  (iCAN):  Pan-European  Conference  on 
Community Empowerment and Sustainable Response to HIV/AIDS’ Conference (Warsaw, PL, 
October 2014); 
the 25th European Organ Donation Congress (Budapest, HU, October 2014); 
the 17th Pancyprian Paediatric Conference (Ayia Naya, CY, October 2014); and 
the 7th Public Health Conference (Glasgow, UK, November 2014). 

Evaluations 

Ex-post evaluation of the anti-tobacco campaign ‘Ex-smokers are unstoppable’ 

Background 

In  2011,  the  European  Commission  launched  the  Ex-smokers  campaign.  The  campaign  aimed  to 
target  smokers  between  the  ages  of  25  to  34  with  the  positive  message  of  ‘ex-smokers  are 
unstoppable’. The campaign is the successor to a previous Commission initiative ‘HELP  — For a life 
without tobacco’ which ran for five years from 2005. The Ex-Smokers campaign aimed to encourage 
young people to give up smoking. There are 28 million smokers in that age group across the EU. 

At the centre of the campaign is the ‘iCoach’ initiative which motivates smokers to follow this step-
by-step  online  platform  to  help  them  give  up  smoking  at  their  own  level.  From  its  launch  on 
16 June 2011  until  it  ended  in  2013,  the  campaign  was  engaged  in  many  activities  to  promote  the 
main message of ‘ex-smokers are unstoppable’. It used online campaigns, TV-advertisements, flyers, 
posters and a range of events to promote the role model of an unstoppable ex-smoker. 

Brief description 

The evaluation’s main objectives were: 

 

 

 

 

to assess the impact of the different campaign actions in terms of their cost-benefit and 
efficiency rated against the actual results achieved; 
to use the results of the evaluation to further improve future initiatives in the same field and 
in other work to promote behavioural change, improve life expectancy and promote a 
healthy lifestyle; 
to identify how the campaign can link in with Member States’ national communication 
campaigns and/or available support structures that promote the same purpose (stopping 
smoking); 
to understand how different factors might affect smokers’ behaviour. This understanding can 
feed into the decision-making process, current European legislation and cross-border 
initiatives on tobacco products. 

Specific results 

19 

 
 
 
Given the complexity of the campaign, it is not possible to define a set of all-encompassing metrics to 
assess  its  performance  in  terms  of  how  many  people  were  reached  by  the  myriad  of  different 
initiatives, how they responded and exactly how far the campaign contributed to further outcomes in 
the short or medium term. 

However,  a  number  of  key  performance  indicators  were  set,  which  provide  evidence  that  can  be 
used to judge the effectiveness of the campaign: 

 

 

reach from paid advertising (TV, print, digital), digital engagement (to a limited extent 
relating to campaign year 3 and the Day of the Ex-smoker campaign) and media coverage 
and message penetration; 
impact and call to action: awareness and smokers’ perception of how the campaign 
influenced their motivation; 

  online word of mouth: social media amplification (likes / comments / shares); 
 

registration and conversions: registrations to iCoach and completion of the health check 
questionnaire. 

Cross-delegations 

Cross sub-delegation and service level agreement with Eurostat Services 

Background 

The cross sub-delegation and service level agreement with Eurostat Services ran from January 2014 
to December 2014 with a maximum co-funding of EUR 1 099 825. The National Statistical Institutes of 
the 28 EU Member States and Iceland, Liechtenstein and Norway were invited to submit proposals. 

Brief description 

The aim of this action was to foster a health knowledge system that would facilitate evidence-based 
decision-making, including collecting and analysing health data. 

Two work packages were proposed: 

• 

• 

the  first  one  (WP1)  open  to  all  countries  on  the  Inventory  on  morbidity  statistics  at 
national level; 
the  second  one 
methodologies for morbidity statistics (through a multi-beneficiary action). 

(WP2)  aimed  at  coordinating  the 

inventories  activities  and 

The action also sought to build statistical capacity in Member States before the Regulation on health 
care  expenditure  became  applicable.  (As  noted  above,  some  EU  countries  were  not  reporting  on 
health expenditure data to Eurostat. Health expenditure data are very much needed for a thorough 
analysis of health systems.) 

The action was dedicated mainly to infrastructural developments such as statistical methodological 
developments and IT developments. Statistical methodological developments included an analysis of 
possible  data  sources  and  elaboration  of  statistical  treatments  to  compile  data  according  to  the 

20 

 
 
‘System of Health Accounts’ (SHA) 2011 Manual.14 IT developments also concerned the infrastructure 
and tools necessary for the collection, compilation, validation and data transmission to Eurostat. The 
action  included  pilot-data/meta-data  transmissions  to  Eurostat.  However,  this  procedure  excluded 
the  official  mandatory  transmissions  required  under  to  the  future  Regulation  on  health  care 
expenditure. 

Specific results 

Morbidity statistics 

The Regulation on health statistics (Regulation (EC) No 1338/2008)15 gives an overall legal framework 
for health data, including morbidity. This action is a follow-up of previous Eurostat projects carried 
out  since  2005  to  implement  morbidity  statistics  within  the  European  Statistical  System.  It  is 
intended  to  help  generate  and  disseminate  health  information  and  knowledge  within  the  Third 
Health Programme. Beneficiaries are to provide Eurostat with inventories specifying data availability, 
access  and  coverage  in  order  to  obtain  best  morbidity  estimates  from  different  sources.  They  will 
also suggest potential ways to fix existing problems. 

In total, 13 grant agreements have been signed on WP1 with Member States. One multi-beneficiary 
grant agreement (4 partners) has been signed on WP2. 

Health expenditure 

The  proposals  aim  at  bringing  significant  ‘infrastructural’  IT  developments  and  technical  and 
methodological  solutions  in  countries  where  the  health  care  financing  accounting  framework  is 
either  immature  or  (partially)  inconsistent  with  the  SHA  2011  methodology.  This  will  ensure  those 
countries comply with the Regulation on health care expenditure and financing adopted in 2015.16 

In total, six grant agreements have been signed. 

14 http://ec.europa.eu/eurostat/documents/3859598/5916161/KS-30-11-270-EN.PDF/655cbab0-4f9d-4d41-
82bb-d39b6fb3f397?version=1.0. 

15 http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32008R1338&from=EN. 

16 http://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:32015R0359&qid=1427698121193&from=EN. 

21 

 
 
                                                            
Other Actions 
Scientific Committees  

In  2014,  a  total  of  EUR 532 000  was  provided  under  the  Third  Health  Programme  to  part-fund  the 
activity  of  the  non-food  scientific  committees  managed  by  the  Directorate-General  for  Health  and 
Food  Safety.  These  committees  assist  the  Commission  by  providing  it  with  sound  scientific  advice 
when preparing policies and proposals related to consumer safety, health and the environment, and 
draw its attention to new and emerging problems. 

The Scientific Committee on consumer safety provided 21 opinions on the health and safety risks of 
non-food consumer products (mainly cosmetic products and their ingredients). The annual review on 
the international dialogue for the evaluation of allergens (IDEA) project was held in Luxembourg to 
report on the project’s progress in establishing risk assessment methodologies, processes and criteria 
to identify fragrance allergens of concern. 

The  Scientific  Committee  on  health  and  environmental  risks  produced  an  opinion  on  the 
environmental risks and indirect health effects of mercury from dental amalgam. 

The Scientific Committee on emerging or newly-identified health and environmental risks produced 
four opinions:  

1.  on the safety of metal-on-metal joint replacements with a particular focus on hip implants;  

2.  on the safety of Poly Implant Prothèse (PIP) silicone breast implants (update 2014);  

3.  on the safety, health and environmental effects of nanosilver and its role in antimicrobial 

resistance; and  

4.  on the definition of synthetic biology.  

The Committee also adopted a position statement on emerging and newly-identified health risks to 
be drawn to the attention of the European Commission. 

A  hearing  and  workshop  on  the  Committee’s  opinion  on  electromagnetic  fields  was  organised  in 
Athens. A conference on the global coordination of radio frequency communications on research and 
health policy (GLORE) was organised in Luxembourg. 

The Third Health Programme provided a total of EUR 330 000 to cover the cost of special indemnities 
paid to experts. The Programme also provided EUR 202 000 to help fund the scientific and technical 
assistance  provided  by  external  contractors.  This  assistance  included  organising  scientific  hearings 
and thematic workshops, performing literature searches, editing and translating scientific texts into 
the  scientific  committees’  website.
publications 

the  general  public  and  updating 

for 

22 

 
 
Statistical overview of the reporting year 

Grants and tenders by Third Health Programme objective 

ACTION GRANTS (PROJECTS) BY OBJECTIVE 
Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic Priority 1.4 
Support cooperation and networking in the Union in relation to preventing and improving the response to chronic 
diseases including cancer, age-related diseases and neurodegenerative diseases 

User reference 

663309 — SPIM EU — 
HP-PJ-2014 
663474 — PATHWAYS — 
HP-PJ-2014 
664258 — EMP-H — HP-
PJ-2014 
664292 — TOB-G — HP-
PJ-2014 
664609 — INPRESD-SA 
— HP-PJ-2014 
TOTAL — OBJECTIVE 1 

Title 

DETERMINANTS OF SUCCESSFUL IMPLEMENTATION OF SELECTIVE 
PREVENTION OF CARDIO-METABOLIC DISEASES ACROSS EUROPE 
Participation To Healthy Workplaces And inclusive Strategies in the Work 
Sector 
Empowering Hospital 

TOBACCO CESSATIION GUIDELINES FOR HIGH RISK GROUPS 

Innovative Prevention Strategies for type 2 Diabetes in South Asians Living in 
Europe 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 

Thematic priority 3.5 
Address health issues in an ageing society  

Title 

FRAILTOOLS: A comprehensive validation of tools to screen and diagnose 
frailty in different clinical and social settings to provide instruments for 
integrated care in older adults 
Stimulating Innovation Management of Polypharmacy and Adherence in The 
Elderly 
Reference Sites Network for Prevention and Care of Frailty and Chronic 
Conditions in community dwelling persons of EU Countries 
Frailty management Optimisation through EIP AHA Commitments and 
Utilisation of Stakeholders input  

User reference 

662887 — FRAILTOOLS 
— HP-PJ-2014 

663082 — SIMPATHY — 
HP-PJ-2014 
664291 — SUNFRAIL — 
HP-PJ-2014 
664367 — FOCUS — HP-
PJ  

2014 

Amount 

854 112.00 

969 379.00 

521 516.28 

541 890.80 

636 500.00 

3 523 398.08 

Amount 

1 124 463.00 

1 015 471.25 

886 193.00 

1 427 779.00 

664509 — EPIC — HP-PJ-
2014 

Empowering pharmacists to improve health care for oral chemotherapy 
patients: Establishment of a European best-practice model  

105 000.00 

664689 — APPCARE — 
HP-PJ-2014 

TOTAL  

Appropriate care paths for frail elderly patients: a comprehensive model 

797 314.00 

5 3562 20.25 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

664317 — EURIPID — 
HP-PJ-2014 

Statistical data and Guidance Document for medicinal product pricing and for 
the use of ERP  

299 999.70 

Thematic Priority 3.7 
Foster a health information and knowledge system to contribute to evidence-based decision-making 

User reference 

664691 — BRIDGE 
HEALTH — HP-PJ-2014

TOTAL — OBJECTIVE 3 

TOTAL PROJECTS 

Title 

Amount 

Bridging Information and Data Generation for Evidence-based Health Policy 

3 497 575.05 

and Research 

9 153 795.00 

12 677 193.08 

23 

 
 
 
 
 
 
 
 
 
 
 
 
 
OPERATING GRANTS BY OBJECTIVE 
Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.1 
Cost-effective promotion and prevention measures in line, in particular, with the Union strategies on alcohol and 
nutrition, and including actions to support the exchange of evidence-based and good practices for addressing risk factors 

User reference 

671355 — OBTAINS-E — 
HP-SGA-2014 
671360 — ENSP FY 2015 
— HP-SGA-2014 
671362 — SFP OPG — 
HP-SGA-2014 
671363 — SHE 
NETWORK — HP-SGA-
2014 
671366 — 
VULNERABILITY NW — 
HP-SGA-2014 
671369 — SOEEFHEALTH 
— HP-SGA-2014 
671370 — EPHA — HP-
SGA-2014 
TOTAL 

Title 

Obesity Training And Information Services for Europe 

ENSP action for year 2015 

Amount 

162 619.00 

293 146.40 

Smoking prevention in action: the Smoke Free Partnership Coalition 

352 054.00 

Schools for Health in Europe network 

170 290.00 

European network to reduce vulnerabilities in health 

294 664.00 

Promote health and reducing health inequalities for people with intellectual 
disability in Europe 
EPHA 2015: Protecting and improving public health and well-being in all 
policies. 

154 356.00 

487 440.60 

1 914 570.00 

Thematic Priority 1.3 
Support effective responses to communicable diseases such as HIV/AIDS, tuberculosis and hepatitis by identifying, 
disseminating and promoting the uptake of evidence-based and good practices for cost-effective prevention, diagnosis, 
treatment and care 

User reference 

671367 — AAE — HP-
SGA-2014 
671368 — TBEC — HP-
SGA-2014 
TOTAL 

Title 

AIDS Action Europe — Continuity and Innovation 

Amount 

268 356.00 

Strengthening the role of civil society within the TB response in Europe 

79 110.00 

347 466.00 

Thematic Priority 1.4 
Support cooperation and networking in the Union in relation to preventing and improving the response to chronic 
diseases including cancer, age-related diseases and neurodegenerative diseases 

Title 

Alzheimer Europe (2015-2017) 

Cancer Leagues Collaborating in Cancer Prevention and Control at the EU and 
National Level 

User reference 

671364 — AE 2015-2017 
— HP-SGA-2014 
671365 — ECL OG 2014 
— HP-SGA-2014 

TOTAL 

TOTAL — OBJECTIVE 1 

Amount 

422 880.00 

314 971.80 

737 851.80 

2 999 887.80 

24 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OPERATING GRANTS BY OBJECTIVE — cont’d 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

671361 — HAI_FY2015 
— HP-SGA-2014 

Health Action International (HAI) Europe Multi-annual Programme 2015-2017: 
Equitable access to medicines, their rational use and good governance in the 
European Union 
Objective 4: 
Facilitate access to better and safer health care for Union citizens 

218 000.00 

Thematic Priority 4.2 
Support Member States, patient organisations and stakeholders by coordinated action at Union level in order to 
effectively help patients affected by rare diseases 

User reference 

671358 — EURORDIS 
FY2015-2017 — HP-SGA-
2014 

Title 

Proposal for Operating Grant Framework Partnership Agreement 2015-2017 
for the European Organisation for Rare Diseases (EURORDIS) 

Thematic Priority 4.3 
Strengthen collaboration on patient safety and quality of health care 

Title 

EUROPEAN PATIENTS’ FORUM — OPERATING GRANT 2015-2017 

User reference 

671359 — EPF FY 2015-
2017 — HP-SGA-2014 
TOTAL OBJECTIVE 4 

TOTAL OPERATING GRANTS 

Amount 

770 000.00 

Amount 

728 212.00 

1 498 212.00 

4 716 099.80 

25 

 
 
 
 
 
 
 
 
 
 
 
 
JOINT ACTIONS BY OBJECTIVE 
Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.1 
Cost-effective promotion and prevention measures in line, in particular, with the Union strategies on alcohol and 
nutrition, and including actions to support the exchange of evidence-based and good practices for addressing risk factors 

User reference 

677063 — JANPA — HP-
JA-2014 

Title 

Joint Action on Nutrition and Physical Activity 

Amount 

1 200 000.00 

Thematic priority 1.3 
Support effective responses to communicable diseases such as HIV/AIDS, tuberculosis and hepatitis by identifying, 
disseminating and promoting the uptake of evidence-based and good practices for cost-effective prevention, diagnosis, 
treatment and care. 

User reference 

677085 — HA-REACT — 
HP-JA-2014 

Title 

Amount 

Joint Action on HIV and Co-infection Prevention and Harm Reduction 

2 999 747.09 

Thematic priority 1.4 
Support cooperation and networking in the Union in relation to preventing and improving the response to chronic 
diseases 
Title 

User reference 

Amount 

678481 — DEM 2 — HP-
JA-2014 

TOTAL OBJECTIVE 1 

Joint Action on Dementia 2015-2018 

1 498 710.30 

5 698 457.39 

Objective 2: 
Protect Union citizens from serious cross-border health threats 
Thematic priority 2.3 
Actions required by, or contributing to, the implementation of Union legislation in the fields of communicable diseases 
and other health threats, including those caused by biological and chemical incidents, environment and climate change. 

User reference 

677066 — EMERGE — 
HP-JA-2014 

Efficient response to highly dangerous and emerging pathogens at EU level 

3 499 873.00 

Title 

Amount 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 
Thematic priority 3.2 
Promote the voluntary uptake of health innovation and eHealth by increasing the interoperability of patient registries 
and other eHealth solutions; support cooperation on eHealth in the Union, in particular on registries, and its uptake by 
health professionals. 

User reference 

677102 — JASEHN — 
HP-JA-2014 

Title 

Joint Action to support the eHealth Network 

Amount 

2 400 000.00 

Thematic priority 3.6 
Actions required by or contributing to the implementation of Union legislation in the field of medical devices, medicinal 
products and cross-border health care. 

User reference 

676988 — COENJA2014 
— HP-JA-2014 

TOTAL OBJECTIVE 3 

Title 

Joint Market Surveillance Actions on medical devices intended to be re-
sterilised focusing on information in the Instruction for use and validation data 
necessary for the re-sterilisation by the user 

Amount 

199 999.00 

2 599 999.00 

26 

 
 
 
 
 
 
 
 
 
 
 
 
JOINT ACTIONS BY OBJECTIVE — cont’d 
Objective 4: 
Facilitate access to better and safer health care for Union citizens 

Thematic Priority 4.2 
Support Member States, patient organisations and stakeholders by coordinated action at Union level in order to 
effectively help patients affected by rare diseases. 

User reference 

Title 

677024 — RD-ACTION — 
HP-JA-2014 

Promoting Implementation of Recommendations on Policy, Information and 
Data for Rare Diseases 

Amount 

4 379 979.00 

Thematic Priority 4.5 
Actions required by, or contributing to, the implementation of Union legislation in the fields of human tissues and cells, 
blood, human organs, medical devices, medicinal products, and patients’ rights in cross-border health care 
Amount 

User reference 

Title 

676969 — VISTART — 
HP-JA-2014 

Vigilance and Inspection for the Safety of Transfusion, Assisted Reproduction 
and Transplantation 

TOTAL OBJECTIVE 4 

GRAND TOTAL JOINT ACTIONS 

2 328 664.00 

6 708 643.00 

18 506 972.39 

DIRECT GRANTS IMPLEMENTED BY CHAFEA BY OBJECTIVE 
Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.1 
Cost-effective promotion and prevention measures in line, in particular, with the Union strategies on alcohol and 
nutrition, and including actions to support the exchange of evidence-based and good practices for addressing risk factors 

User reference 

20145101 / WHO 

20145102 / WHO 

TOTAL OBJECTIVE 1 

Title 

Monitoring of the national policies related to nutrition, physical 
inactivity overweight- and obesity-related diseases in all the Member 
States 
Monitoring of the national policies related to alcohol consumption 
and harm reduction 

Amount 

600 000.00 

500 000.00 

1 100 000.00 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 
Thematic priority 3.6 
Actions required by or contributing to the implementation of Union legislation in the field of medical devices, medicinal 
products and cross-border health care. 

User reference 

2014 53 01 COE 2015 
ACTIVITY 
PROGRAMME 

Title 

Amount 

European Pharmacopoeia 

1 100 000.00 

Objective 4: 
Facilitate access to better and safer health care for Union citizens 

Thematic Priority 4.5 
Actions required by, or contributing to, the implementation of Union legislation in the fields of human tissues and cells, 
blood, human organs, medical devices, medicinal products, and patients’ rights in cross-border health care 
Amount 

User reference 

Title 

20145401 / COE 

Integration of the EU legislation on substances of human origin and 
the outcomes of EU funded project actions in this area into the 
Council of Europe actions 

TOTAL DIRECT GRANTS 

500 000.00 

2 700 000.00 

27 

 
 
 
 
 
 
 
 
 
 
DIRECT GRANTS IMPLEMENTED BY DG SANTE BY OBJECTIVE 
Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.6 
Health information and knowledge system 

User reference 

Title 

TOTAL OBJECTIVE 1 

Direct grant to Eurostat (cross-subdelegation) 
Direct grant to Eurostat (cross-subdelegation) 

Amount 

685 691.27 
414 134.69 
1 099 825.96 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 
Thematic priority 3.6 
Actions required by or contributing to the implementation of Union legislation in the field of medical devices, medicinal 
products and cross-border health care. 

User reference 

Title 

 TRAINING IN THE AREA OF ACTIVE PHARMACEUTICAL INGREDIENTS 
— Direct grant to the Pharmaceutical Inspection Cooperation Scheme 

GRAND TOTAL DIRECT GRANTS 

Amount 

50 000.00 

1 149 825.96 

PRESIDENCY CONFERENCES BY OBJECTIVE 

Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.1 
Cost-effective promotion and prevention measures in line, in particular, with the Union strategies on alcohol and 
nutrition, and including actions to support the exchange of evidence-based and good practices for addressing risk factors 

User reference 

Title 

Healthy lifestyles: nutrition and physical activity for children and young 
people at schools 

Amount 

57 901.00 

HMA — Health in the Mediterranean Area Conference 

100 000.00 

2014 00 02 HEALTHY LIFESTYLES 
— PRESIDENTIAL CONFERENCE 
OF LATVIA 

2014 00 01 — Presidency 
Conference Italy 

GRAND TOTAL PRESIDENCY CONFERENCES 

157 901.00 

28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE 

Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.1 
Cost-effective promotion and prevention measures in line, in particular, with the Union strategies on alcohol and 
nutrition, and including actions to support the exchange of evidence-based and good practices for addressing risk factors 

User reference 

Title 

C1 — EVALUATION OF THE ANTI-TOBACCO CAMPAIGN 

C4 — MONITORING OF THE EU PLATFORM ON DIET, PHYSICAL 
ACTIVITY & HEALTH 

Amount 

589 114.00 

99 738.00 

C4 — MONITORING THE UE ALCOHOL & HEALTH FORUM 

99 814.00 

TOTAL 

788 666.00 

Thematic priority 1.5 
Actions required by, or contributing to, the implementation of Union legislation in the field of tobacco products, 
advertising and marketing 

User reference 

Title 

D4 — TOBACCO LEGISLATION 

TOTAL OBJECTIVE 1 

Amount 

 564 534.72 

1 353 200.72 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 
Thematic priority 3.1 
Support voluntary cooperation between Member States on health technology assessment under the network on health 
technology assessment set up by Directive 2011/24/EU. 

User reference 

Title 

B2/A4/DIGIT — HOSTING 

Amount 

78 158.42 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

User reference 

Title 

D5/A4 — EMP DATABASE 

D5 — ICH REFORM & IPRF FORUM 

D2/04 — VIDEO ON NATIONAL CONTACT POINTS ON CROSS-
BORDER HEALTH CARE 

D2 — ASSESSMENT OF IMPLEMENTATION OF PATIENTS’ 
RIGHTS DIRECTIVE 

Amount 

75 596.00 

150 000.00 

30 000.00 

434 098.16 

SC 1552 — AC — ENTERPRISE ARCHITECT LEVEL 3 — AV1 BA 

15 000.00 

SC 1429 — GQ — SECURITY CONSULTANT FOR ADNS — MOD 
BA 

15 000.00 

29 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE — cont’d 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

OF 810 — RENEWAL VARIOUS LICENCES 

5 208.46 

SC 1930 DB — APPLICATION ARCHITECT FOR EMP 

78 156.00 

TOTAL 

SC 241 — RD — TEAM COORDINATOR FOR EMP 

41 635.54 

844 694.16 

Thematic priority 3.7 
Foster a health information and knowledge system to contribute to evidence-based decision-making  

User reference 

Title 

C2/D3 — SCIENTIFIC & TECHNICAL ASSISTANCE FOR 
SCIENTIFIC COMMITTEES AND THE EXPERT PANEL 

Cost/benefit analysis of a sustainable EU health information 
system (EUHIS) 

TOTAL 

TOTAL OBJECTIVE 3 

Amount 

289 183.21 

115 300.00 

404 483.21 

1 327 335.79 

Objective 4: 
Facilitate access to better and safer health care for Union citizens 
Thematic priority 4.1 
Support the establishment of a system of European reference networks for patients with conditions requiring highly 
specialised care and a particular concentration of resources or expertise 

User reference 

Title 

D2/A4 — EU REFERENCE NETWORK  

SC 827 — CLC — DATABASE DEVELOPER FOR EUROPEAN 
NETWORKS — MOD BA 

Amount 

187 621.94 

25 000.00 

SC 931 — EM — APPLICATION ARCHITECT FOR CATALOGUES 

20 000.00 

SC 1315 — EN — APPLICATION ARCHITECT FOR TRACES 

30 000.00 

SC 1653 — MF — PROJECT MANAGER FOR REFERENCE 
NETWORKS — MOD BA — MOD MT 

SC 1632 — JS — APPLICATION ARCHITECT FOR HEALTH 
POLICIES 

65 709.21 

15 000.00 

SC 2311 — PH — PROJECT MANAGER FOR NETWORKS 

40 000.00 

SC 1123 — DC — APPLICATION DEVELOPER FOR HEALTH 

30 000.00 

30 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE — cont’d 

Thematic priority 4.1 
Support the establishment of a system of European reference networks for patients with conditions requiring highly 
specialised care and a particular concentration of resources or expertise 

User reference 

Title 

SC 2699 — YW — APPLICATION ARCHITECT FOR DATA 
COLLECTION 

TOTAL 

Amount 

59 679.00 

473 010.15 

Thematic priority 4.4 
Improve the prudent use of antimicrobial agents and reduce the practices that increase antimicrobial resistance; promote 
effective prevention and hygiene measures to prevent and control infections; reduce the burden of resistant infections 
and health care-associated infections and secure the availability of effective antimicrobials 

User reference 

Title 

C3 — AMR — 3rd REPORT ON IMPLEMENTATION OF REC 
77/2002/EC ON PRUDENT USE OF ANTIMICROBIAL AGENTS 

Amount 

14 703.00 

Thematic priority 4.5 
Actions required by, or contributing to, the implementation of Union legislation in the fields of human tissues and cells, 
blood, human organs, medical devices, medicinal products, and patients’ rights in cross-border health care 

User reference 

Title 

Amount 

D4 — EB ON DONATION OF HUMAN BLOOD, TISSUES & CELLS 

245 971.20 

TOTAL OBJECTIVE 4 

Objective 5: 
Horizontal actions (IT actions) 

A4 — HOSTING SANCO 

C/D/04 — COMMUNICATION & PROMOTION OF INFO ON EU 
HEALTH POLICIES & RESULTS OF HEALTH PROGRAMME 

C-D COMMUNICATION, PROMOTION, DISSEMINATION OF 
INFO ON EU HEALTH POLICIES & RESULTS OF THE HEALTH 
PROGRAMMES 

733 684.35 

49 147.20 

120 800.62 

582 625.48 

C/D/04 — COMMUNICATION & PROMOTION OF INFO ON EU 
HEALTH POLICIES & RESULTS OF HEALTH PROGRAMME 

503 000.00 

C-D COMMUNICATION, PROMOTION, DISSEMINATION OF 
INFO ON EU HEALTH POLICIES & RESULTS OF THE HEALTH 
PROGRAMMES 

C-D COMMUNICATION, PROMOTION, DISSEMINATION OF 
INFO ON EU HEALTH POLICIES & RESULTS OF THE HEALTH 
PROGRAMMES 

2 459.57 

115 715.20 

C-D/A4 IT SERVICES — INFORMATION TECHNOLOGIES IN 
SUPPORT OF PUBLIC HEALTH POLICIES 

1 084 819.08 

31 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE — cont’d 

Objective 5: 
Horizontal actions (IT actions) — cont’d 
C-D/A4/DIGIT — HOSTING PART OF INFORMATION 
TECHNOLOGIES IN SUPPORT OF PUBLIC HEALTH POLICIES 

2014-16071 COMLIN ASSOCIATION MOMENTANEE*, CS1922A, 
CC06730 

2014-16207 COMLIN ASSOCIATION MOMENTANEE*, CS1922B, 
CC06730 

2014-16258 BECHTLE AG*, CS348,CC07210 

CC06730, CS2075, 2014-17341, COMLIN ASSOCIATION 
MOMENTANEE* 

CC06730, CS2076, 2014-17410, COMLIN ASSOCIATION 
MOMENTANEE* 

32 464.20 

42 090.57 

28.01 

36 795.78 

28 826.15 

28 826.15 

CC 30CE04896380063, OF 159, 2014-17559, SOCOM SA* 

17 858.42 

CC OIB.DR.2/PR/2011/064/444/C1/L2, CS 160, 2014-19227, 
SOCOM SA* 

CC07210, CS420, 2014-21098, BECHTLE AG* 

CC07210, CS419, 2014-21206, BECHTLE AG* 

CC06820, CS3697-CE, 2014-21532, COMPAREX NEDERLAND 
BV* 

CC07190, CS1037, 2014-22729, BECHTLE AG* 

CC06720, CS2116, 2014-23084, ECONOCOM PRODUCTS & 
SOLUTIONS BELUX 

CC07210, CS442, 2014-25224, BECHTLE AG* 

CC06820, CS3706-CE, 2014-25670, COMPAREX NEDERLAND 
BV* 

CC 30-CE-0489638:00-63 (OIB.DR.2/PR/2011/064/444/C1/L2), 
CS 169, 2014-32766, SOCOM SA* 

13 962.00 

20 772.82 

20 772.82 

10 011.50 

8 681.04 

6 894.48 

79 604.05 

15 228.00 

265.62 

CC 30-CE-0489638/00-63, CS167, 2014-32771, SOCOM SA* 

9 318.02 

CC OIB.DR.2/PR/2011/064/444/C1/L2, CS172, 2014-33137, 
SOCOM SA* 

CC06730, CS2307, 2014-33854, COMLIN ASSOCIATION 
MOMENTANEE* 

CC06730, CS2308, 2014-33874, COMLIN ASSOCIATION 
MOMENTANEE* 

CC07210, CS468, 2014-33933, BECHTLE AG* 

1 426.44 

2.67 

127.87 

724.00 

32 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE — cont’d 

Objective 5: 
Horizontal actions (IT actions) — cont’d 

CC07210, CS539, 2014-35563, BECHTLE AG* 

GROW.R.3 — SC 1094 — CC DI/7330 — EURORA — 
DEJONCKHEERE — EUDAMED 

GROW/R3 — CS 2863 — CC DI/7331 — PANOPLYS — 
HOULIHAN 

GROW/R3 — CS 3412 — CC DI/7335 — TUZUNOGLU — 
INNOVATIA  

GROW/R3 — CS 3410 — CC DI/7333 — EUROPEAN DYNAMICS 
— RATOI  

54.97 

109 804.00 

126 843.20 

91 035.30 

62 660.00 

GROW/R3 — CS 3405 -CC DI/7331 — AUCLERT — PANOPLYS 

26 317.50 

GROW/R3 — CS 3751 — CC DI/7335 — SAITAS — INNOVATIA  

18 118.20 

SC 930 — YW — APPLICATION ARCHITECT/DESIGNER LEVEL 5 
— MOD BL 

33 464.00 

SC 1552 — AC — ENTERPRISE ARCHITECT LEVEL 3 — AV1 BA 

19 154.00 

SC 824 — MF — APPLICATION ARCHITECT FOR HEALTH 
POLICIES — COR BA 

SC 827 — CLC — DATABASE DEVELOPER FOR EUROPEAN 
NETWORKS — MOD BA 

SC 830 — JA — DATABASE DEVELOPER FOR HEALTH POLICIES 
— AV1 BA 

SC 832 -CBT — BUSINESS INTELLIGENCE ANALYST FOR HEALTH 
POLICIES 

SC 966 -VC — DATABASE DEVELOPER FOR CPCS NET 

SC 1057 — CF — PROJECT MANAGER FOR ODR — MOD BA 

SC 1429 — GQ — SECURITY CONSULTANT FOR ADNS — MOD 
BA 

52 635.00 

70 300.00 

104 830.00 

76 425.60 

15 000.00 

32 154.00 

19 154.00 

SC 931 — EM — APPLICATION ARCHITECT FOR CATALOGUES 

18 464.00 

SC 932 — GB — APPLICATION ARCHITECT FOR EUROPHYT 

35 057.00 

SC 1050 — RMT — APPLICATION ARCHITECT FOR ADIS 

27 899.00 

33 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY DG SANTE BY OBJECTIVE — cont’d 

Objective 5: 
Horizontal actions (IT actions) — cont’d 
SC 1324 — FM — BUSINESS ANALYST FOR HEALTH SYSTEMS 

PO 20150312 — PARTICIPATION OF DG SANTE IN IHE EUROPE 
CONNECTATHON 2015 

SC 1632 — JS — APPLICATION ARCHITECT FOR HEALTH 
POLICIES 

63 688.00 

5 303.00 

56 051.00 

SC 1120 — GS — BUSINESS ANALYST FOR IT SUPPOR 

35 000.00 

SC 1602 — BS — APPLICATION ARCHITECT FOR FOOD & FEED 

20 000.00 

SC 2311 — PH — PROJECT MANAGER FOR NETWORKS 

41 853.00 

SC 1107 — ADW — DATABASE DEVELOPER FOR HEALTH 

57 729.00 

SC 1123 — DC — APPLICATION DEVELOPER FOR HEALTH 

14 495.40 

OF 1010 — PURCHASE FILEMAKER LICENCE 

OF 1052 — PURCHASE NEW ENDNOTE LICENCE 

SC 2943 — MF — PROJECT MANAGER FOR HORIZONTAL 
ACTIONS 

2 899.33 

404.38 

1 055.82 

OF 1077 — RENEWAL MAINTENANCE SAP POWERDESIGNER 

896.56 

TOTAL OBJECTIVE 5 

GRAND TOTAL CALLS FOR TENDER 

4 071 993.02 

7 486 213.88 

34 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY CHAFEA BY OBJECTIVE 

Objective 1: 
Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 
‘health in all policies’ principle 
Thematic priority 1.4 
Support cooperation and networking in the Union in relation to preventing and improving the response to chronic 
diseases including cancer, age-related diseases and neurodegenerative diseases  

User reference 

Title 

2014 71 03 — 
CHAFEA/2014/HEALTH/02 — 
MENTAL HEALTH — 
TRIMBOS INSTITUUT 

MENTAL HEALTH — TRIMBOS INSTITUUT 

Amount 

799 777.00 

Thematic priority 1.5 
Actions required by, or contributing to, the implementation of Union legislation in the field of tobacco products, 
advertising and marketing 

User reference 

Title 

Study on the identification of potential risks to public health 
associated with the use of refillable electronic cigarettes and 
development of technical specifications for refill mechanisms 

TOBACCO LABELLING — WARNING MESSAGES ON TOBACCO 
PACKAGES 

BRFAA EUREST 

2014 71 01 SC ON FWC 
EAHC/2013/HEALTH/23/ 
RFS/CHAFEA/2014/HEALTH/
17/EUREST/PRESICE 

2014 71 02 SC ON FWC NO 
EAHC/2013/HEALTH/10 LOT 
2  
2014 71 04 
CHAFEA/2015/HEALTH/02 
(SC) BRFAA EUREST 
TOTAL 

TOTAL OBJECTIVE 1 

Objective 2: 
Protect Union citizens from serious cross-border health threats 
Thematic priority 2.2 
Support capacity-building against health threats in Member States 

User reference 

Title 

2014 63 05 ON 
EAHC/2012/HEALTH/01/RFS 
CHAFEA/2014/HEALTH/21 
2014 72 01 SC ON FWC 
EAHC/2012/HEALTH/01/PHE
/CHAFEA/2014/HEALTH/12 
2014 72 03 -
CHAFEA/2015/HEALTH/01 — 
IMPLEMENTING FWC 
EAHC/2012/HEALTH/01  
2014 72 05-
CHAFEA/2014/HEALTH/06-
CIVIC CONSULTING 

TOTAL OBJECTIVE 2 

Preparedness activities relevant to the monitoring, the 
assessment and the coordination of the response 

COMMAND POST EXERCISE ON SERIOUS CROSS-BORDER 
THREATS TO HEALTH 

Preparedness and response activities in the context of the 
Ebola epidemic in West Africa 

STUDY ON COST-BENEFIT ANALYSIS OF REFERENCE 
LABORATORIES FOR HUMAN PATHOGENS 

Amount 

180 450.00 

80 000.00 

220 740.00 

481 190.00 

1 280 967.00 

Amount 

643 559.25 

458 988.80 

499 719.35 

199 942.00 

1 802 209.40 

35 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY CHAFEA BY OBJECTIVE — cont’d 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 
Thematic priority 3.3 
Support the sustainability of the health workforce by developing effective health workforce forecasting and planning  

User reference 

2014 73 05 
CHAFEA/2014/HEALTH/04 
NIVEL  

Title 

HEALTH CARE ASSISTANTS 

Amount 

195 350.00 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

User reference 

Title 

Amount 

2014 73 01 SC ON FWC 
EAHC/2013/HEALTH/01/LOT
2 -CHAFEA/2014/HEALTH/07 
ECORYS  
2014 73 02 SC ON FWC 
EAHC/2013/HEALTH/01/LOT
2 -CHAFEA/2014/HEALTH/08 
— SOGETI 
2014 73 03 SC ON FWC 
EAHC/2013/HEALTH/01/LOT
2 -CHAFEA/2014/HEALTH/09 
— SOGETI 
2014 73 06 — RFS09 — 
CHAFEA/2014/HEALTH/24 
IMPL FWC EAHC/2013/ 
HEALTH/ LOT 1 ECORYS  
2014 73 07 — 
CHAFEA/2014/HEALTH/27 
IMPL FWC EAHC/2013/ 
HEALTH/ LOT 1 NIVEL  
TOTAL 

TOTAL OBJECTIVE 3 

Health-related constraints to raising Retirement Ages in the EU 

58 875.00 

A probabilistic Markov Model of age-related disability rates for 
selected disease causes and related impacts on public payer 
cash benefit expenditure 

136 640.00 

Study on enhanced cross-country coordination in the area of 
pharmaceutical product pricing 

86 062.50 

STUDY ON THE REGULATION OF ADVANCED THERAPIES 

161 500.00 

Study on off label use of medicinal products in the European 
Union 

226 500.00 

669 577.50 

864 927.50 

Objective 4: 
Facilitate access to better and safer health care for Union citizens 
Thematic priority 4.1 
Support the establishment of a system of European reference networks for patients with conditions requiring highly 
specialised care and a particular concentration of resources or expertise, as in the case of rare diseases, on the basis of 
criteria to be established under Directive 2011/24/EU 

User reference 

Title 

2014 73 04 
CHAFEA/2014/HEALTH/03  

MAPPING OF PATIENTS’ RIGHTS IN ALL MEMBER STATES IN 
THE EUROPEAN UNION 

2014 73 08 
CHAFEA/2014/HEALTH/10 
(SC) on FWC EAHC/2013/ 
HEALTH/01 — LOT 2 
2014 74 01-
CHAFEA/2014/HEALTH/05 -
EURORDIS 
2014 74 02 — 
CHAFEA/2014/HEALTH/25 — 
PWC 
TOTAL 

Study on cross-border health services: potential obstacles for 
health care providers 

DEVELOPMENT OF A MANUAL AND TOOLBOX FOR THE 
ASSESSMENT OF EUROPEAN REFERENCE NETWORKS 

STUDY ON SERVICES TO BE PROVIDED BY EUROPEAN 
REFERENCE NETWORKS 

Amount 

154 799.00 

211 550.00 

499 254.00 

172 660.00 

1 038 263.00 

36 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CALLS FOR TENDERS IMPLEMENTED BY CHAFEA BY OBJECTIVE — cont’d 

Thematic priority 4.3 
Strengthen collaboration on patient safety and quality of health care 

User reference 

Title 

2014 61 01 SC ON FWC 
EAHC/2013/HEALTH/01/LOT
2 CHAFEA 2014/HEALTH/11 
— SOGETI 
TOTAL OBJECTIVE 4 

Study on costs of unsafe care and cost-effectiveness of patient 
safety programmes 

2014 72 04 SC ON FWC NO 
CHAFEA/2013/HEALTH/14  

VIDEO PRODUCTION ON EBOLA 

Objective 5: 
Horizontal actions (communication actions)  

2014 63 07 SC ON FWC NO 
CHAFEA/2013/HEALTH/14 -  

PROVIDE SUPPORT TO CHAFEA FOR EUROPEAN ORGAN 
DONATIION CONGRESS IN BUDAPEST OCT 2014 AND HIV2014 
CONF OCT 2014 IN BARCELONA — NOOKOM 

2014 63 09 SC ON FWC NO 
CHAFEA/2013/HEALTH/14 

EXTERNAL ASSIST FOR EXT COMM IN PUBLIC HEALTH, 
CONSUMERS AND FOOD SAFETY, TO PROVIDE LOGISTIC AND 
TECHNICAL SUPPORT IN ORDER FOR CHAFEA TO PARTICIPATE 
IN 4 EVENTS IN 4 EU COUNTRIES — NOOKOM 

TOTAL OBJECTIVE 5 

GRAND TOTAL CALLS FOR TENDER 

Amount 

174 900 

1 213 163.00 

59 350.94 

24 638.36 

37 822.36 

121 811.66 

5 283 078.56 

37 

 
 
 
 
 
 
 
 
OTHER ACTIONS IMPLEMENTED BY DG SANTE BY OBJECTIVE 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 

Thematic priority 3.1 
Support voluntary cooperation between Member States on health technology assessment under the network on health 
technology assessment set up by Directive 2011/24/EU. 

User reference 

Title 

B2 — REIMBURSEMENTS OF EXPERTS’ EXPENSES FOR JOINT 
ASSESSMENTS 

Amount 

100 000 

Thematic priority 3.4 
Setting up a mechanism for pooling expertise at Union level, to provide sound and evidence-based advice on effective 
and efficient investment and innovation in public health and health systems. 

User reference 

Title 

D3 — EXPERT PANEL ON EFFECTIVE WAYS OF INVESTING IN 
HEALTH 

Amount 

258 720 

Thematic priority 3.6 
Implementation of Union legislation in the field of medical devices, medicinal products and cross-border health care 

User reference 

Title 

D5 — DEVELOPMENT OF EU REQUIREMENTS FOR MEDICINAL 
PRODUCTS FOR HUMAN USE TROUGH ICH 

D6 — VICH (experts indemnities) 

D6 — ACTIVE PHARMACEUTICAL INGREDIENTS (system 
inspections) 

TOTAL 

Amount 

221 073.04 

12 000 

32 000 

265 073.04 

Thematic priority 3.7 
Foster a health information and knowledge system to contribute to evidence-based decision-making  

User reference 

Title 

C2 — SCIENTIFIC COMMITTEES (special indemnities) 

GRAND TOTAL OTHER ACTIONS 

Amount 

150 000 

773 793.04 

OTHER ACTIONS IMPLEMENTED BY CHAFEA BY OBJECTIVE 

Objective 3: 
Contribute to innovative, efficient and sustainable health systems 

Thematic priority 3.7 
Foster a health information and knowledge system to contribute to evidence-based decision-making  

User reference 

Title 

GRAND TOTAL OTHER ACTIONS 

EUROPEAN OBSERVATORY ON HEALTH SYSTEMS & POLICY 

Amount 

500 000 
500 000 

38 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Funding per thematic priority and financial instrument 

Projects 

3rd Health 
Programme 
objectives 
Objective 1 — Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the ‘health in all policies’ principle 

Other 
actions — 
SANTE 

Direct 
Grants — 
SANTE 

Direct 
Grants — 
Chafea 

Joint Actions  Operating 

Tender — 
Chafea 

Tender- 
SANTE 

Presid. 
Conf. 

Grants 

Other 
actions — 
Chafea 

Total per 
thematic 
priority 

1 200 000.00  1 914 570.00  1 100 000.00  0.00 

157 901.00 

788 666.00 

0 

0 

0 

5 161 137.00 

0 

0 

0 

1.1 — Cost-
effective 
promotion and 
prevention 
measures  

1.2 — Action in 
reducing drug-
related health 
damage 

1.3 — Effective 
responses to 
communicable 
diseases  

1.4 — Preventing 
and improving 
the response to 
chronic diseases  

0 

0 

0 

2 999 747.09  347 466.00 

0 

3 523 398.08 

1 498 710.30  737 851.80 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

799 777.00 

0 

0 

0 

0 

0 

3 347 213.09 

6 559 737.18 

39 

 
 
0 

0 

0 

0 

0 

0 

564 534.72 

481 190.00 

0 

0 

1 045 724.72 

1.5 — 
Implementation 
of Union 
legislation in the 
field of tobacco 
products, 
advertising and 
marketing 

1.6 — Health 
information and 
knowledge 
system  

0 

0 

0 

0.00 

1 099 825.96 

0 

0 

0 

TOTAL 

3 523 398.08 

5 698 457.39  2 999 887.80  1 100 000.00  1 099 825.96  157 901.00 

1 353 200.72 

1 280 967.00 

0 

Objective 2 — Protect Union citizens from serious cross-border health threats 

0 

0 

0 

0 

3 499 873.00 

0 

0 

0 

0 

0 

0 

0 

2.1 — Risk 
assessment 

2.2 — Capacity-
building against 
health threats in 
Member States 

2.3 — 
Implementation 
of Union 
legislation in the 
fields of 
communicable 

0 

0 

0 

40 

0 

0 

0 

0 

0 

0 

0 

0 

1 802 209.40 

0 

0 

0 

0 

0 

0 

0 

0 

1 099 825.96 

17 213 637.95 

0 

1802209.4 

3499873 

 
 
 
diseases and 
other health 
threats 

2.4 — Health 
information and 
knowledge 
system  

TOTAL 

0 

0 

0 

0 

3 499 873.00 

0 

0 

0 

Objective 3 — Contribute to innovative, efficient and sustainable health systems 

0 

0 

0 

3.1 — Voluntary 
cooperation on 
health 
technology 
assessment 

3.2 — Voluntary 
uptake of health 
innovation and 
eHealth  

3.3 — 
Sustainability of 
the health 
workforce  

0 

0 

2 400 000.00 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

41 

0 

0 

0 

0 

1 802 209.40 

0 

0 

0 

0 

5 302 082.40 

78 158.42 

0 

100 000 

0 

178158.42 

0 

0 

0 

0 

195 350.00 

0 

0 

0 

2400000 

195350 

 
 
0 

0 

0 

0 

0 

0 

0 

0 

258 720 

0 

258720 

5 356 220.25  0 

0 

0 

0 

0 

0 

0 

0 

0 

5 356 220.25 

299 999.70 

199 999.00 

218 000.00 

1 100 000.00  50 000.00 

0 

844 694.16 

669 577.50 

265 073.04  0 

3 647 343.40 

3 497 575.05  0 

0 

0 

0 

0 

404 483.21 

0 

150 000 

500 000 

4 552 058.26 

3.4 — 
Mechanism to 
provide advice 
on effective and 
efficient 
investment and 
innovation in 
public health and 
health systems 

3.5 — Address 
health issues in 
an ageing society 

3.6 — 
Implementation 
of Union 
legislation in the 
field of medical 
devices, 
medicinal 
products and 
cross-border 
health care 

3.7 — Health 
information and 
knowledge 
system  

TOTAL 

9 153 795.00  2 599 999.00 

0 

1 100 000.00  50 000.00 

0 

1 327 335.79 

864 927.50 

773 793.04  0 

16 587 850.33 

42 

 
 
Objective 4 — Facilitate access to better and safer health care for Union citizens 

0 

0 

0 

0.00 

0 

4 379 979.00 

770 000.00 

0 

0 

0 

0 

0 

473 010.15 

1 038 263.00 

0 

0 

1 511 273.15 

0 

0 

0 

0 

5 149 979.00 

0 

0 

728 212.00 

0 

0 

0 

0 

174 900 

0 

0 

903 112.00 

4.1 — 
Establishment 
of European 
reference 
networks  

4.2 — 
Coordinated 
action at Union 
level in order to 
effectively help 
patients 
affected by rare 
diseases 

4.3 — 
Strengthen 
collaboration 
on patient 
safety and 
quality of 
health care 

43 

 
 
4.4 — Improve 
the prudent use 
of antimicrobial 
agents and 
reduce the 
practices that 
increase 
antimicrobial 
resistance 

4.5 — 
Implementation 
of Union 
legislation in 
the fields of 
human tissues 
and cells, 
blood, human 
organs, medical 
devices, 
medicinal 
products, and 
patients’ rights 
in cross-border 
health care 

4.6 — Health 
information 
and knowledge 
system  

0 

0 

0 

0 

0 

0 

14 703.00 

0 

0 

0 

14 703.00 

0 

2 328 664.00 

0.00 

500 000.00 

0.00 

0 

245 971.20 

0 

0 

0 

3 074 635.20 

0 

0.00 

0.00 

0.00 

0.00 

0 

0.00 

0 

0 

0 

0.00 

44 

 
 
TOTAL 

0 

6 708 643.00 

1 716 212.00  500 000.00 

0.00 

5 — Horizontal (IT, communication) actions 

0 

0 

CHAFEA — 
communication 

SANTE — IT 

TOTAL — 
horizontal 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

0 

733 684.35 

1 213 163.00 

0 

500 000.00  10 653 702.35 

0.00 

121 811.66 

0 

4 071 993.02 

0 

0 

0 

0 

121 811.66 

4 071 993.02 

4 193 804.68 

Total 

12 677 193.08  18 506 972.39 

4 716 099.80  2 700 000.00  1 149 825.96  157 901.00 

7 486 213.88 

5 283 078.56 

773 793.04  500 000.00  53 951 077.71 

45